CDC expands updated COVID-19 vaccines to children ages 5 to 11 | CDC Online Newsroom | Techy Kings

[ad_1]

Today, CDC Director Rochelle P. Walensky, MD, MPH, signed a decision memo expanding the use of updated (bivalent) COVID-19 vaccines to children ages 5 to 11 years. This follows the Food and Drug Administration’s (FDA) approval of updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 to 11 years and from Moderna for children and adolescents ages 6 to 17 years.

Updated covid-19 vaccines add Omicron BA.4 and BA.5 spike protein components to the current vaccine formulation, helping to restore protection that has waned since previous vaccination and targeting newer Omicron variants that are more transmissible and immune evasion.

The FDA’s approval of updated (bivalent) COVID-19 vaccines for this younger age group, and the CDC’s recommendation for use, are critical next steps forward in our nation’s vaccination program—a program that has helped provide increased protection against severe COVID -19 disease and death.

[ad_2]

Source link